Warfarin Patients Who Have A Stroke - Outcomes With Anti-Clotting Agents
A study in the June 27 edition of JAMA reports that patients treated with warfarin (with an INR 1.7 or less) who had an acute ischemic stroke were not linked to a higher risk of symptomatic intracranial hemorrhage when using intravenous tissue plasminogen activator (tPA) compared with patients who were not treated with warfarin as standard treatment...
Indique esta NotÃcia
Compartilhar
